SPRO logo

SPROSpero Therapeutics Inc

$2.87
$0.11
(3.69%)
Today
Updated: 11:36 AM EDT
Reported EarningsMay 13
Mkt Cap$172.55M
Vol299,106.00

About

Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on identifying, developing, and commercializing treatments involving bacterial infections, including multi-drug resistant bacterial infections, and rare diseases Its pipeline product candidates include Tebipenem HBr, SPR720, and SPR206. The company was founded by Ankit A. Mahadevia and Laurence Rahme in April 2013 and is headquartered in Cambridge, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
25

Frequently Asked Questions

What is Market Cap of Spero Therapeutics Inc?
What is the 52-week high for Spero Therapeutics Inc?
What is the 52-week low for Spero Therapeutics Inc?
What is Spero Therapeutics Inc stock price today?
What was Spero Therapeutics Inc stock price yesterday?
What is the PE ratio of Spero Therapeutics Inc?
What is the Price-to-Book ratio of Spero Therapeutics Inc?
What is the 50-day moving average of Spero Therapeutics Inc?
How many employees does Spero Therapeutics Inc have?

Advertisement|Remove ads.